                 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
                            REGION IX AIR DIVISION

                          Technical Support Document
                                      for
                              EPA's Rulemaking
                                    for the
                     California State Implementation Plan

             Placer County Air Pollution Control District Rule 250
                            Stationary Gas Turbines

                            Prepared by: Kevin Gong
                                April 20, 2016

RULE IDENTIFICATION -
Agency
Placer County Air Pollution Control District  (PCAPCD)

SIP Approved Rule
Rule 250  -  Stationary Gas Turbines
Adopted  -  October 17, 1994
Submitted  -  October 19, 1994
EPA Approved  -  August 23, 1995 (60 FR 43713)

Subject of this TSD
Rule 250  -  Stationary Gas Turbines
Amended  -  October 8, 2015
Submitted  -  March 11, 2016

Completeness Finding
Determination of Completeness letter  -  April 19, 2016

BACKGROUND
PCAPCD regulates a portion of the Sacramento Metropolitan Nonattainment Area, which is classified as a "severe" nonattainment area (NAA) for the 1994 1-hour ozone National Ambient Air Quality Standard (NAAQS), and for the 1997 8-hour ozone and 2008 8-hour ozone NAAQS (see 40 CFR part 81). The Clean Air Act (CAA) requires that for areas classified as moderate or above nonattainment, the State must submit revisions to the State Implementation Plan (SIP) requiring the implementation of reasonably available control technology (RACT) (see sections 182(b)(2) and 182(f)). This rule was revised in part to ensure continued compliance with the CAA RACT requirement and to update the rule to comply with EPA policy on start-up and shutdown emissions.

RULE SUMMARY
Rule 250 limits oxides of nitrogen emissions (NOx) from stationary gas turbines in Placer County. It includes exemptions for laboratory and testing units, firefighting and flood control units, emergency standby and small units, and low-use units. The rule also contains generally applicable emission limits, operating and emission limits for units in startup and shutdown, monitoring and recordkeeping requirements, and references for test methods. Changes to Rule 250 from the SIP-approved version include:

1.	Removal of exemptions for pipeline and chemical processing turbines, as none exist in the district, and addition of an exemption for low-use units.

2.	Removal of obsolete definitions, and the inclusion of definitions for performance testing, startup and shutdown.

3.	Simplification of emission limitations, through the removal of efficiency factor calculations.

4.	Inclusion of startup and shutdown emission limits and operating procedures to minimize emissions during these conditions.

5.	Requirements for all units to install NOx monitors, unless exempt.

6.	Changes in recordkeeping practices to require longer maintenance of records (5 years instead of 2).

7.	Other minor changes to improve clarity and reduce redundancy in language.

EVALUATION CRITERIA
1.	Enforceability - The Bluebook (Issues Relating to VOC Regulation Cutpoints, Deficiencies, and Deviations, EPA, May 25, 1988) and the Little Bluebook (Guidance Document for Correcting Common VOC & Other Rule Deficiencies, EPA Region 9, August 21, 2001) were used to help evaluate compliance with the CAA §110(a)(2)(A) requirement for enforceability. In addition, we refer to Restatement and Update of EPA's SSM Policy Applicable to SIPs (80 FR 33839, June 12, 2015), with respect to emissions during start-up, shut-down and malfunction (SSM) conditions discussed in Rule 250. In general, this EPA policy clarifies the requirement for continuous emission limitations, consistent with the CAA.

      2.	Stringency - SIPs must require RACT for each category of sources covered by a Control Technique Guideline (CTG) document as well as each major source in ozone nonattainment areas (see sections 182(b)(2) and 182(f)). While there is no CTG for this source category, EPA has published an Alternative Control Techniques (ACT) document titled, "NOx Emissions from Stationary Gas Turbines" (EPA 453/R-93-007, January 1993) which describes available control techniques and their estimated costs. This ACT and other state and local rules for this category were used to help evaluate the RACT requirements of CAA §182(b)(2) and §182(f).

      3.	SIP Relaxation - CAA §110(l) prohibits EPA from approving any SIP revision that would interfere with any applicable requirement concerning attainment and reasonable further progress (RFP) or any other applicable requirement of the CAA. In addition, CAA §193 prohibits the modification of any SIP-approved control requirement in effect before November 15, 1990, in a nonattainment area.

EPA EVALUATION
A summary of our evaluation of the three criteria follows.

      1. 	The provisions of Rule 250 clearly define the types of turbines that must comply with this rule. Requirements are clearly written, and the monitoring, recordkeeping, and reporting provisions will sufficiently ensure that any affected sources can determine compliance against the outlined limits.

      	The previous version of Rule 250 excluded startup and shutdown emissions from control measures, but the most recent revision removes the exemption and replaces it with new restrictions during these operating periods. Combined cycle turbine units now must comply with emission limits during startup and shutdown. Simple cycle units must operate in a manner that minimizes emissions during startup and shutdown, including: following manufacturer's recommendations for operation during startup and shutdown, maintaining proper air to fuel ratios, and initiating water injection as soon as reasonably possible. These numerical limits and work practices comply with EPA's recently updated policy by establishing continuous emission limitations during SSM events.

      2. 	The submitted rule is as stringent as other California District rules for this category, including Yolo-Solano AQMD Rule 2.34, and Mojave Desert AQMD Rule 1158, and it is more stringent than EPA's 1993 ACT guideline. As a result, we have determined that this rule fulfills RACT requirements. New rule provisions regulating operations and emissions during startup and shutdown operations improve stringency in comparison to the SIP-approved version of this rule.

      	The deletion of a category for units 10 megawatt and larger, operating without selective catalytic reduction (SCR) and a higher emission limit, has the effect of requiring any units subject to the rule at that size to comply with the more stringent limits for 10 megawatt and larger units operating with SCR (now applicable to all units at that size). The new rule also removes exemptions for gas pipeline and chemical processing turbines.

      3. 	We propose to determine that our approval of the submittal would comply with CAA §§110(l) and 193 because (1) the proposed SIP revision would not interfere with the ongoing process for ensuring that requirements for RFP and attainment of the NAAQS are met, and (2) the emission limits in the submitted rule are more stringent than the existing SIP-approved control requirements that they would replace.

EPA ACTION
The submitted Rule 250 strengthens the SIP for the reasons outlined above, and the rule fulfills the relevant CAA §110 and part D requirements. Therefore, EPA staff recommends approval of PCAPCD Rule 250 pursuant to CAA §110(k)(3) and §301(a).

REFERENCES

 "Issues Relating to VOC Regulation Cutpoints, Deficiencies, and Deviations," (a.k.a., Bluebook) EPA OAQPS, May 25, 1988.
 "Guidance Document for Correcting Common VOC & Other Rule Deficiencies," (a.k.a., Little Bluebook), EPA Region 9, August 21, 2001.
 Placer County Air Pollution Control District Rule 250, "Stationary Gas Turbines," as amended October 8, 2015 and submitted to EPA on March 11, 2015.
 Mojave Desert Air Quality Management District Rule 1159, "Stationary Gas Turbines," as amended September 29, 2009.
 Yolo-Solano Air Quality Management District Rule 2.34, "Stationary Gas Turbines," as amended November 12, 2014.
 "Alternative Control Techniques Document  -  NOx Emissions from Stationary Gas Turbines," (EPA-453/R-93-007), Emissions Standards Division, EPA OAQPS, January 1993.
 "Restatement and Update of EPA's SSM Policy Applicable to SIPs," 80 FR 33839, June 12, 2015.


[Federal Register: October 26, 2007 (Volume 72, Number 207)]
[Notices]
[Page 60832]
[DOCID:fr26oc07-46]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ID-4025-001]

Brown, D. Tim; Notice of Filing

October 18, 2007.
    Take notice that on October 15, 2007, Tim D. Brown filed an
application for approval to hold interlocking positions, pursuant to
section 45.8 of the Commission's regulation, 18 CFR 45.8 (2007).
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date.
Anyone filing a motion to intervene or protest must serve a copy of
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on November 14, 2007.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-21155 Filed 10-25-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 175 (Tuesday, September 10, 2019)]
[Notices]
[Pages 47629-47630]
[FR Doc No: 2019-19485]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket Number FRA-2019-0061]

Petition for Waiver of Compliance

    Under part 211 of title 49 Code of Federal Regulations (CFR), this
document provides the public notice that on August 28, 2019, the Port
Terminal Railroad Association (PTRA), petitioned the Federal Railroad
Administration (FRA) for a waiver of compliance from certain provisions
of the Federal railroad safety regulations contained at 49 CFR part
240, Qualification and Certification of Locomotive Engineers, and part
242, Qualification and Certification of Conductors. FRA assigned the
petition Docket Number FRA-2019-0061.

    The relief is requested as part of PTRA's proposed implementation
of and participation in FRA's Confidential Close Call Reporting System
(C\3\RS) Program. PTRA seeks to shield reporting employees and the
railroad from mandatory punitive sanctions that would otherwise arise
as provided in 49 CFR 240.117(e)(1)-(4); 240.305(a)(l)-(4) and (a)(6);
240.307; 242.403(b), (c), (e)(l)-(4), (e)(6)-(11), (f)(l)-(2); and
242.407. The C\3\RS Program encourages certified operating crew members
to report close calls and protect the employees and the railroad from
discipline or sanctions arising from the incidents reported per the
C\3\RS Implementing Memorandum of Understanding.
    A copy of the petition, as well as any written communications
concerning the petition, is available for review online at
www.regulations.gov and in person at the U.S. Department of
Transportation's (DOT) Docket Operations Facility, 1200 New Jersey
Avenue SE, W12-140, Washington, DC 20590. The Docket Operations
Facility is open from 9 a.m. to 5 p.m., Monday through Friday, except
Federal Holidays.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested parties
desire an opportunity for oral comment and a public hearing, they
should notify FRA, in writing, before the end of the comment period and
specify the basis for their request.
    All communications concerning these proceedings should identify the
appropriate docket number and may be submitted by any of the following
methods:
     Website: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue SE, W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue SE, Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal Holidays.
    Communications received by October 25, 2019 will be considered by
FRA before final action is taken. Comments received after that date
will be considered if practicable.
    Anyone can search the electronic form of any written communications
and comments received into any of our dockets by the name of the
individual submitting the comment (or signing the document, if
submitted on behalf of an association, business, labor union, etc.).
Under 5 U.S.C. 553(c), DOT solicits comments from the public to better
inform its processes. DOT posts these comments, without edit, including
any personal information the commenter provides, to
www.regulations.gov, as described in the system of records notice (DOT/
ALL-14 FDMS), which can be reviewed at https://www.transportation.gov/privacy. See also https://www.regulations.gov/privacyNotice for the
privacy notice of regulations.gov.

    Issued in Washington, DC.
John Karl Alexy,
Associate Administrator for Railroad Safety, Chief Safety Officer.
[FR Doc. 2019-19485 Filed 9-9-19; 8:45 am]
 BILLING CODE 4910-06-P


[Federal Register Volume 81, Number 248 (Tuesday, December 27, 2016)]
[Rules and Regulations]
[Pages 94987-94991]
[FR Doc No: 2016-31084]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 520 and 529

[Docket No. FDA-2016-N-0002]

Oral Dosage Form New Animal Drugs; Approval of New Animal Drug
Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of 43 supplemental new animal drug
applications (NADAs) and 52 supplemental abbreviated new animal drug
applications (ANADAs) for revised labeling reflecting a change in
marketing status from over-the-counter (OTC) to prescription (Rx) for
antimicrobial drugs of importance to human medicine administered to
food-producing animals in medicated drinking water. These applications
were submitted in voluntary compliance with the goals of the FDA Center
for Veterinary Medicine's (CVM's) Judicious Use Initiative.

DATES: This rule is effective December 31, 2016.

FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: FDA is amending the animal drug regulations
to reflect approval of 43 supplemental NADAs and 52 supplemental ANADAs
for revised labeling reflecting a change in marketing status from OTC
to Rx for antimicrobial drugs of importance to human medicine
administered to food-producing animals in medicated drinking water.
These applications were identified as being affected by guidance for
industry (GFI) #213, ``New Animal Drugs and New Animal Drug Combination
Products Administered in or on Medicated Feed or Drinking Water of
Food-Producing Animals: Recommendations for Drug Sponsors for
Voluntarily Aligning Product Use Conditions with GFI #209,'' December
2013 (http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624.pdf). Their
change to Rx marketing status is consistent with the FDA CVM's
initiative for the Judicious Use of Antimicrobials. The affected
applications follow:

------------------------------------------------------------------------
          File No.             Animal drug product         Sponsor
------------------------------------------------------------------------
006-084.....................  SULMET                Huvepharma EOOD, 5th
                               (sulfamethazine)      Floor, 3A Nikolay
                               Drinking Water        Haytov Str., 1113
                               Solution.             Sophia, Bulgaria
                                                     (Huvepharma EOOD).
006-677.....................  S.Q.                  Huvepharma EOOD.
                               (sulfaquinoxaline)
                               20% Solution.
006-707.....................  SULQUIN 6-50          Zoetis Inc., 333
                               (Sulfaquinoxaline).   Portage St.,
                                                     Kalamazoo, MI 49007
                                                     (Zoetis Inc.).
006-891.....................  SUL-Q-NOX             Huvepharma EOOD.
                               (sulfaquinoxaline)
                               Solution.
007-087.....................  Sulfaquinoxaline      Huvepharma EOOD.
                               Solubilized
                               (Powder).
008-622.....................  TERRAMYCIN            Zoetis Inc.
                               (oxytetracycline)
                               Soluble Powder.
011-315.....................  NEOMIX 325            Zoetis Inc.
                               (neomycin) Soluble
                               Powder.
015-160.....................  Sodium                Zoetis Inc.
                               Sulfachloropyrazine
                               Solution.
031-205.....................  AGRIBON               Zoetis Inc.
                               (sulfadimethoxine)
                               12.5% Drinking
                               Water Solution.
031-553.....................  ESB 3                 Zoetis Inc.
                               (sulfachloropyrazin
                               e) Soluble Powder/
                               Solution.
032-946.....................  MAGNA TERRAMYCIN      Zoetis Inc.
                               (oxytetracycline
                               and carbomycin)
                               Soluble Powder.
033-373.....................  VETSULID SP           Huvepharma EOOD.
                               (sulfachloropyridaz
                               ine) Soluble Powder.
035-157.....................  GALLIMYCIN            Cross Vetpharm Group
                               (erythromycin)        Ltd., Broomhill
                               Soluble Powder.       Rd., Tallaght,
                                                     Dublin 24, Ireland
                                                     (Cross Vetpharm
                                                     Group Ltd.).
038-200.....................  MEDAMYCIN             Phibro Animal Health
                               (oxytetracycline)     Corp., GlenPointe
                               Soluble Powder.       Centre East, 3d
                                                     floor, 300 Frank W.
                                                     Burr Blvd., suite
                                                     21, Teaneck, NJ
                                                     07666 (Phibro
                                                     Animal Health
                                                     Corp.).
038-661.....................  SPECTOGARD            Cross Vetpharm Group
                               (spectinomycin)       Ltd.
                               Water Soluble
                               Powder.
046-109.....................  L-S 50 (lincomycin    Zoetis Inc.
                               and spectinomycin)
                               Water Soluble
                               Powder.
046-285.....................  AGRIBON               Zoetis Inc.
                               (sulfadimethoxine)
                               Soluble Powder.
055-012.....................  CHLORONEX SULMET      Huvepharma EOOD.
                               (chlortetracycline
                               bisulfate and
                               sulfamethazine)
                               Soluble Powder.
055-020.....................  AUREOMYCIN            Zoetis Inc.
                               (chlortetracycline)
                               Soluble Powder.
055-060.....................  Penicillin G          Zoetis Inc.
                               Potassium, USP.
065-071.....................  AUREOMYCIN            Huvepharma EOOD.
                               (chlortetracycline)
                               Soluble Powder.
065-123.....................  Tetracycline Soluble  Zoetis Inc.
                               Powder.
065-140.....................  TET-SOL 324           Huvepharma EOOD.
                               (tetracycline)
                               Soluble Powder.
065-178.....................  FERMYCIN              Phibro Animal Health
                               (chlortetracycline)   Corp.
                               Soluble.
065-256.....................  CHLORO-SOLUBLE-O      Pharmgate LLC, 1015
                               (chlortetracycline)   Ashes Dr., suite
                               Soluble Powder.       102, Wilmington, NC
                                                     28405 (Pharmgate
                                                     LLC).
065-269.....................  POLYOTIC              Huvepharma EOOD.
                               (tetracycline)
                               Soluble Powder.
065-410.....................  TETRA-SAL             Zoetis Inc.
                               (tetracycline)
                               Soluble Powder.
065-440.....................  CHLORONEX             Huvepharma EOOD.
                               (chlortetracycline)
                               Soluble Powder.
065-441.....................  POLYOTIC              Zoetis Inc.
                               (tetracycline)
                               Soluble Powder
                               Concentrate.
065-480.....................  Chlortetracycline     Pharmgate LLC.
                               Soluble Powder.
065-486.....................  Chlortetracycline     Strategic Veterinary
                               Bisulfate Soluble     Pharmaceuticals,
                               Powder.               Inc., 100 NW.
                                                     Airport Rd., St.
                                                     Joseph, MO 64503
                                                     (Strategic Vet.
                                                     Pharm., Inc.).
065-496.....................  Tetracycline Soluble  Phibro Animal Health
                               Powder.               Corp.
091-191.....................  GENTOCIN              Intervet, Inc., 2
                               (gentamicin) Oral     Giralda Farms,
                               Solution.             Madison, NJ 07940
                                                     (Intervet, Inc.).
100-094.....................  POULTRY SULFA         Huvepharma EOOD.
                               (sulfamerazine,
                               sulfamethazine, and
                               sulfaquinoxaline)
                               Soluble Powder.
106-964.....................  APRALAN (apramycin)   Elanco US Inc.
                               Soluble Powder.
111-636.....................  LINCOMIX              Zoetis Inc.
                               (lincomycin)
                               Soluble Powder.

122-272.....................  SULMET                Huvepharma EOOD.
                               (sulfamethazine)
                               Soluble Powder.
130-435.....................  OXY-TET               Huvepharma EOOD.
                               (oxytetracycline)
                               Soluble Powder.
133-836.....................  GARACIN (gentamicin)  Intervet, Inc.
                               Soluble Powder.
140-578.....................  SOLU-TET 324          Zoetis Inc.
                               (tetracycline)
                               Soluble Powder.
200-026.....................  PENNOX 343            Pharmgate LLC.
                               (oxytetracycline).
200-030.....................  Sulfadimethoxine      Agri Laboratories,
                               12.5% Oral Solution.  Ltd., P.O. Box
                                                     3103, St. Joseph,
                                                     MO 64503 (Agri
                                                     Laboratories,
                                                     Ltd.).
200-031.....................  Sulfadimethoxine      Agri Laboratories,
                               Antibacterial         Ltd.
                               Soluble Powder.
200-046.....................  Neomycin Soluble      Zoetis Inc.
                               Powder.
200-049.....................  Tetracycline          Agri Laboratories,
                               Hydrochloride         Ltd.
                               Soluble Powder-324.
200-050.....................  NEOMED (neomycin)     Cross Vetpharm Group
                               Soluble Powder.       Ltd.
200-066.....................  AGRIMYCIN-343         Agri Laboratories,
                               (oxytetracycline)     Ltd.
                               Soluble Powder.
200-103.....................  PENAQUA SOL-G         Cross Vetpharm Group
                               (penicillin G         Ltd.
                               potassium) Soluble
                               Powder.
200-106.....................  R-PEN (penicillin G   Huvepharma EOOD.
                               potassium) Soluble
                               Powder.
200-113.....................  BIOSOL[supreg]        Zoetis Inc.
                               (neomycin) Liquid.
200-118.....................  Neomycin Oral         Huvepharma EOOD.
                               Solution.
200-122.....................  SOLU-PEN (penicillin  Zoetis Inc.
                               G potassium)
                               Soluble Powder.
200-130.....................  NEO-SOL 50            Zoetis Inc.
                               (neomycin) Soluble
                               Powder.
200-136.....................  Tetracycline          Quo Vademus, LLC,
                               Hydrochloride         277 Faison McGowan
                               Soluble Powder-324.   Rd., Kenansville,
                                                     NC 28349 (Quo
                                                     Vademus, LLC).
200-144.....................  Oxytetracycline HCl   Cross Vetpharm Group
                               Soluble Powder.       Ltd.
200-146.....................  TETROXY 25            Cross Vetpharm Group
                               (oxytetracycline).    Ltd.
200-153.....................  NEO 200 (neomycin)    Huvepharma EOOD.
                               Oral Solution.
200-165.....................  SDM                   Strategic Vet.
                               (sulfadimethoxine)    Pharm., Inc.
                               12.5% Oral Solution.
200-185.....................  GEN-GARD (Gentamicin  Agri Laboratories,
                               sulfate) Soluble      Ltd.
                               Powder.
200-189.....................  Lincomycin Soluble..  Huvepharma EOOD.
200-190.....................  GENTORAL (gentamicin  Med-Pharmex, Inc.,
                               sulfate) Oral         2727 Thompson Creek
                               Solution.             Rd., Pomona, CA
                                                     91767-1861 (Med-
                                                     Pharmex, Inc.).
200-192.....................  Sulfadimethoxine      Huvepharma EOOD.
                               12.5% Oral Solution.
200-197.....................  Streptomycin Oral     Huvepharma EOOD.
                               Solution w/STREP
                               SOL (RLNAD 065-252).
200-233.....................  LINCO (lincomycin)    Zoetis Inc.
                               Soluble Powder.
200-234.....................  TETRASOL              Med-Pharmex, Inc.
                               (tetracycline)
                               Soluble Powder.
200-235.....................  NEOSOL (neomycin)     Med-Pharmex, Inc.
                               Soluble Powder.
200-236.....................  Chlortetracycline     Quo Vademus, LLC.
                               HCL Soluble Powder.
200-238.....................  SULFASOL              Med-Pharmex, Inc.
                               (sulfadimethoxine)
                               Soluble Powder.
200-241.....................  LINCOSOL              Med-Pharmex, Inc.
                               (lincomycin)
                               Soluble Powder.
200-247.....................  TETROXY 343           Cross Vetpharm Group
                               (oxytetracycline)     Ltd.
                               Soluble Powder.
200-251.....................  SULFORAL              Med-Pharmex, Inc.
                               (Sulfadimethoxine)
                               Soluble Powder.
200-258.....................  Sulfadimethoxine      Phibro Animal Health
                               Soluble Powder.       Corp.
200-289.....................  NEOSOL-ORAL           Med-Pharmex, Inc.
                               (neomycin) Soluble
                               Powder.
200-295.....................  PENNCHLOR 64          Pharmgate LLC.
                               (chlortetracycline)
                               Soluble Powder.
200-303.....................  Lincomycin            Quo Vademus, LLC.
                               Hydrochloride
                               Soluble Powder.
200-345.....................  Lincomycin-           Phibro Animal Health
                               Spectinomycin         Corp.
                               Soluble Powder.
200-347.....................  Penicillin G          Quo Vademus, LLC.
                               Potassium USP.
200-372.....................  HAN-PEN (penicillin   G.C. Hanford
                               G potassium)          Manufacturing Co.,
                               Soluble Powder.       P.O. Box 1017,
                                                     Syracuse, NY 13201
                                                     (G.C. Hanford Mfg.
                                                     Co.).
200-374.....................  TETRAMED 324 HCA      Cross Vetpharm Group
                               (tetracycline)        Ltd.
                               Soluble Powder.
200-376.....................  SULFAMED-G            Cross Vetpharm Group
                               (sulfadimethoxine)    Ltd.
                               Soluble Powder.
200-377.....................  LINXMED-SP            Cross Vetpharm Group
                               (lincomycin and       Ltd.
                               spectinomycin)
                               Soluble Powder.
200-378.....................  Neomycin Sulfate 325  Sparhawk
                               Soluble Powder.       Laboratories, Inc.,
                                                     12340 Santa Fe
                                                     Trail Dr., Lenexa,
                                                     KS 66215 (Sparhawk
                                                     Laboratories,
                                                     Inc.).
200-379.....................  Neomycin Liquid.....  Sparhawk
                                                     Laboratories, Inc.
200-380.....................  SPECLINX-50           Cross Vetpharm Group
                               (lincomycin and       Ltd.
                               spectinomycin)
                               Soluble Powder.
200-407.....................  Lincomycin-           Agri Laboratories,
                               Spectinomycin Water   Ltd.
                               Soluble Powder.
200-434.....................  SMZ-MED 454           Cross Vetpharm Group
                               (sulfamethazine)      Ltd.
                               Soluble Powder.
200-441.....................  AUREOMYCIN            Huvepharma EOOD.
                               (chlortetracycline)
                               Soluble Powder.
200-443.....................  Sulfadimethoxine      First Priority,
                               Soluble Powder.       Inc., 1590 Todd
                                                     Farm Dr., Elgin, IL
                                                     60123.
200-460.....................  TETROXY AQUATIC       Cross Vetpharm Group
                               (oxytetracycline)     Ltd.
                               Soluble Powder.
200-494.....................  GENTAMED              Cross Vetpharm Group
                               (gentamicin)          Ltd.
                               Soluble Powder.
------------------------------------------------------------------------

    The animal drug regulations are also being amended to reflect
several non-substantive changes in format. These technical amendments
are being made to improve the consistency and readability of the
regulations.
    Elsewhere in this issue of the Federal Register, FDA is amending
the animal drug regulations to reflect approval of similar supplemental
NADAs and ANADAs changing the marketing status of antimicrobial drugs
administered to food-producing animals in medicated feed.
    This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Parts 520 and 529

    Animal drugs.

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR parts 520 and
529 are amended as follows:

PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

0
1. The authority citation for part 520 continues to read as follows:

    Authority:  21 U.S.C. 360b.

Sec.  520.110  [Amended]

0
2. In Sec.  520.110, in paragraph (d)(3), remove ``Prepare fresh
medicated water daily.'' and as the last sentence add ``Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.''

Sec.  520.441  [Amended]

0
3. In Sec.  520.441, in paragraphs (d)(1)(i)(A)(2), (d)(2)(i)(A)(2),
(d)(4)(i)(A)(2), (d)(4)(i)(B)(2), (d)(4)(ii)(A)(2), (d)(4)(ii)(B)(2),
(d)(4)(iii)(C), (d)(4)(iv)(C), (d)(5)(i)(A)(2), (d)(5)(ii)(A)(2),
(d)(5)(iii)(C), and (d)(5)(iv)(C), as the last sentence add ``Federal
law restricts this drug to use by or on the order of a licensed
veterinarian.''

Sec.  520.445  [Amended]

0
4. In Sec.  520.445, in paragraph (d)(3), as the last sentence add
``Federal law restricts this drug to use by or on the order of a
licensed veterinarian.''

0
5. In Sec.  520.823, revise paragraphs (d)(1)(i), (d)(1)(iii),
(d)(2)(i), (d)(2)(iii), (d)(3)(i), and (d)(3)(iii) to read as follows:

Sec.  520.823  Erythromycin.

* * * * *
    (d) * * *
    (1) * * *
    (i) Amount. Administer 0.500 gram per gallon for 5 days.
* * * * *
    (iii) Limitations. Do not use in replacement pullets over 16 weeks
of age. Do not use in chickens producing eggs for human consumption.
Withdraw 1 day before slaughter. Federal law restricts this drug to use
by or on the order of a licensed veterinarian.
    (2) * * *
    (i) Amount. Administer 0.500 gram per gallon for 7 days.
* * * * *
    (iii) Limitations. Do not use in replacement pullets over 16 weeks
of age. Do not use in chickens producing eggs for human consumption.
Withdraw 1 day before slaughter. Federal law restricts this drug to use
by or on the order of a licensed veterinarian.
    (3) * * *
    (i) Amount. Administer 0.500 gram per gallon for 7 days.
* * * * *
    (iii) Limitations. Do not use in turkeys producing eggs for human
consumption. Withdraw 1 day before slaughter. Federal law restricts
this drug to use by or on the order of a licensed veterinarian.

0
6. In Sec.  520.1044a, revise paragraph (d)(3) to read as follows:

Sec.  520.1044a  Gentamicin sulfate oral solution.

* * * * *
    (d) * * *
    (3) Limitations. Do not slaughter treated swine for food for at
least 3 days following treatment. Federal law restricts this drug to
use by or on the order of a licensed veterinarian.

0
7. In Sec.  520.1044c, remove paragraph (d)(4) and revise paragraph
(d)(3) to read as follows:

Sec.  520.1044c  Gentamicin sulfate powder.

* * * * *
    (d) * * *
    (3) Limitations. Withdrawal period: 10 days. Federal law restricts
this drug to use by or on the order of a licensed veterinarian.

Sec.  520.1263c  [Amended]

0
8. In Sec.  520.1263c, in paragraph (b)(1), remove ``No. 016592'' and
in its place add ``Nos. 016592 and 054771''; in paragraph (d)(1)(iii),
remove ``051259'' and in its place add ``054925'', and as the last
sentence add ``Federal law restricts this drug to use by or on the
order of a licensed veterinarian.''; and in paragraphs (d)(2)(iii) and
(d)(3)(iii), add ``Federal law restricts this drug to use by or on the
order of a licensed veterinarian.''

0
9. In Sec.  520.1265, add paragraph (d)(3) to read as follows:

Sec.  520.1265  Lincomycin and spectinomycin powder.

* * * * *
    (d) * * *
    (3) Limitations. Federal law restricts this drug to use by or on
the order of a licensed veterinarian.

0
10. In Sec.  520.1484, revise paragraphs (e)(1)(iii) and (e)(2)(iii) to
read as follows:

Sec.  520.1484  Neomycin.

* * * * *
    (e) * * **
    (1) * * *
    (iii) Limitations. Discontinue treatment prior to slaughter as
follows: Cattle, 1 day; sheep, 2 days; swine and goats, 3 days. Federal
law restricts this drug to use by or on the order of a licensed
veterinarian.
    (2) * * *
    (iii) Limitations. Federal law restricts this drug to use by or on
the order of a licensed veterinarian.

0
11. In Sec.  520.1660a, revise the section heading and paragraphs
(e)(1) and (e)(3) to read as follows:

Sec.  520.1660a  Oxytetracycline and carbomycin.

* * * * *
    (e) * * *
    (1) Amount. Administer 1.0 gram of oxytetracycline and 1.0 gram
carbomycin per gallon for not more than 5 days.
* * * * *
    (3) Limitations. Not for use in chickens producing eggs for human
consumption. Withdraw 24 hours before slaughter. Federal law restricts
this drug to use by or on the order of a licensed veterinarian.

0
12. In Sec.  520.1660d, revise paragraphs (d)(1)(i)(A)(1),
(d)(1)(i)(A)(3), (d)(1)(i)(B)(1), (d)(1)(i)(B)(3), (d)(1)(ii)(A)(1),
(d)(1)(ii)(A)(3), (d)(1)(ii)(B)(1), (d)(1)(ii)(B)(3), (d)(1)(ii)(C)(1),
(d)(1)(ii)(C)(3), (d)(1)(iii)(A), (d)(1)(iii)(C), (d)(1)(iv)(A),
(d)(1)(iv)(C), (d)(1)(v)(A), (d)(1)(v)(C), (d)(2)(i), and (d)(2)(iii)
to read as follows:

Sec.  520.1660d  Oxytetracycline powder.

* * * * *
    (d) * * *
    (1) * * *
    (i) * * *
    (A) * * *
    (1) Amount. Administer 200 to 400 milligrams/gallon for 7 to 14
days. Not to be used for more than 14 consecutive days.
* * * * *
    (3) Do not use in birds producing eggs for human consumption.
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
    (B) * * *
    (1) Amount. Administer 400 to 800 milligrams/gallon for 7 to 14
days. Not to be used for more than 14 consecutive days.
* * * * *
    (3) Do not use in birds producing eggs for human consumption.
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
    (ii) * * *
    (A) * * *
    (1) Amount. Administer 200 to 400 milligrams/gallon for 7 to 14
days. Not to be used for more than 14 consecutive days.
* * * * *
    (3) Do not use in birds producing eggs for human consumption.
Withdraw 5 days prior to slaughter those products sponsored by Nos.
054771 and 061623 in Sec.  510.600(c) of this chapter. Withdraw 4 days
prior to slaughter

those products sponsored by No. 054628. Zero-day withdrawal for those
products sponsored by Nos. 057561 and 069254. Federal law restricts
this drug to use by or on the order of a licensed veterinarian.
    (B) * * *
    (1) Amount. Administer 400 milligrams/gallon for 7 to 14 days. Not
to be used for more than 14 consecutive days.
* * * * *
    (3) Do not use in birds producing eggs for human consumption.
Withdraw 5 days prior to slaughter those products sponsored by Nos.
054771 and 061623 in Sec.  510.600(c) of this chapter. Withdraw 4 days
prior to slaughter those products sponsored by No. 054628. Zero-day
withdrawal for those products sponsored by Nos. 057561 and 069254.
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
    (C) * * *
    (1) Amount. Administer 25 milligrams per pound of body weight daily
for 7 to 14 days. Not to be used for more than 14 consecutive days.
* * * * *
    (3) Do not use in birds producing eggs for human consumption.
Withdraw 5 days prior to slaughter those products sponsored by Nos.
054771 and 061623 in Sec.  510.600(c) of this chapter. Withdraw 4 days
prior to slaughter those products sponsored by No. 054628. Zero-day
withdrawal for those products sponsored by Nos. 057561 and 069254.
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.
    (iii) * * *
    (A) Amount. Administer 10 milligrams per pound of body weight daily
for up to 14 days. Do not use for more than 14 consecutive days.
* * * * *
    (C) Withdraw zero days prior to slaughter those products sponsored
by Nos. 054771, 057561, 061623, and 069254 in Sec.  510.600(c) of this
chapter. Withdraw 4 days prior to slaughter those products sponsored by
No. 054628. Federal law restricts this drug to use by or on the order
of a licensed veterinarian.
    (iv) * * *
    (A) Amount. Administer 10 milligrams per pound of body weight daily
for up to 14 days. Do not use for more than 14 consecutive days.
* * * * *
    (C) Withdraw 5 days prior to slaughter. A milk discard period has
not been established for this product in lactating dairy cattle. Do not
use in female dairy cattle 20 months of age or older. Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.
    (v) * * *
    (A) Amount. Administer 10 milligrams per pound of body weight daily
for up to 14 days. Not to be used for more than 14 consecutive days.
* * * * *
    (C) Withdraw 5 days prior to slaughter. Federal law restricts this
drug to use by or on the order of a licensed veterinarian.
    (2) * * *
    (i) Amount. 200 milligrams per colony, administered via either a
1:1 sugar syrup (equal parts of sugar and water weight to weight) or
dusting with a powdered sugar mixture. The drug is administered in 3
applications of sugar syrup or 3 dustings at 4- to 5-day intervals.
* * * * *
    (iii) The drug should be fed early in the spring or fall and
consumed by the bees before main honey flow begins to avoid
contamination of production honey. Remove at least 6 weeks prior to
main honey flow. Federal law restricts this drug to use by or on the
order of a licensed veterinarian.

0
13. In Sec.  520.1696b, redesignate paragraph (c) as paragraph (d) and
add new paragraph (c), and revise redesignated paragraph (d)(3) to read
as follows:

Sec.  520.1696b  Penicillin G powder.

* * * * *
    (c) Related tolerances. See Sec.  556.510 of this chapter.
* * * * *
    (d) * * *
    (3) Limitations. Discontinue treatment at least 1 day prior to
slaughter. Not for use in turkeys producing eggs for human consumption.
Federal law restricts this drug to use by or on the order of a licensed
veterinarian.

Sec.  520.2123b  [Amended]

0
14. In Sec.  520.2123b, remove paragraph (d)(1)(i); redesignate
paragraphs (d)(1)(ii) and (iii) as paragraphs (d)(1)(i) and (ii); and
in paragraph (d)(2), as the last sentence add ``Federal law restricts
this drug to use by or on the order of a licensed veterinarian.''

Sec.  520.2184  [Amended]

0
15. In Sec.  520.2184, in paragraph (d)(3), remove the first sentence,
and as the last sentence add ``Federal law restricts this drug to use
by or on the order of a licensed veterinarian.''

Sec.  520.2200  [Amended]

0
16. In Sec.  520.2200, in paragraphs (d)(1)(iii) and (d)(2)(iii), as
the last sentence add ``Federal law restricts this drug to use by or on
the order of a licensed veterinarian.''

Sec.  520.2218   [Amended]

0
17. In Sec.  520.2218, in paragraphs (d)(1)(ii) and (d)(2)(ii), remove
the first sentence, and as the last sentence add ``Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.''

0
18. In Sec.  520.2220a, revise the section heading and paragraphs
(d)(1)(iii), (d)(2)(iii), and (d)(3)(iii) to read as follows:

Sec.  520.2220a  Sulfadimethoxine oral solution and soluble powder.

* * * * *
    (d) * * *
    (1) * * *
    (iii) Limitations. Withdraw 5 days before slaughter. Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.
    (2) * * *
    (iii) Limitations. Withdraw 5 days before slaughter. Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.
    (3) * * *
    (iii) Limitations. Withdraw 7 days before slaughter. A withdrawal
period has not been established for this product in preruminating
calves. Do not use in calves to be processed for veal. Federal law
restricts this drug to use by or on the order of a licensed
veterinarian. Federal law prohibits the extralabel use of this product
in lactating dairy cattle.

Sec.  520.2261a  [Amended]

0
19. In Sec.  520.2261a, in paragraph (d)(3), as the last sentence add
``Federal law restricts this drug to use by or on the order of a
licensed veterinarian.''

Sec.  520.2261b  [Amended]

0
20. In Sec.  520.2261b, in paragraphs (d)(1)(iii), (d)(2)(iii),
(d)(3)(iii), and (d)(4)(iii), as the last sentence add ``Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.''

Sec.  520.2325a  [Amended]

0
21. In Sec.  520.2325a, in paragraph (d), remove the first sentence,
and as the last sentence add ``Federal law restricts this drug to use
by or on the order of a licensed veterinarian.''

Sec.  520.2345d   [Amended]

0
22. In Sec.  520.2345d, in paragraphs (d)(1)(iii), (d)(2)(iii),
(d)(3)(iii), and (d)(4)(iii), as the last sentence add ``Federal law
restricts this drug to use by or on the order of a licensed
veterinarian.''

PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS

0
23. The authority citation for part 529 continues to read as follows:

    Authority:  21 U.S.C. 360b.

0
24. In Sec.  529.1660, add paragraph (d)(3) to read as follows:

Sec.  529.1660   Oxytetracycline.

* * * * *
    (d) * * *
    (3) Limitations. Federal law restricts this drug to use by or on
the order of a licensed veterinarian.

    Dated: December 20, 2016.
Tracey H. Forfa,
Deputy Director, Center for Veterinary Medicine.
[FR Doc. 2016-31084 Filed 12-23-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 170 (Wednesday, September 3, 2014)]
[Notices]
[Pages 52347-52348]
[FR Doc No: 2014-20883]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2014-0801]

Commercial Fishing Safety Advisory Committee

AGENCY: Coast Guard, Department of Homeland Security.

ACTION: Notice of Federal Advisory Committee Meeting.

-----------------------------------------------------------------------

SUMMARY: The Commercial Fishing Safety Advisory Committee will meet in
Providence, Rhode Island to discuss various issues relating to safety
in the commercial fishing industry. This meeting will be open to the
public.

DATES: The Committee will meet on Tuesday, September 23 and Wednesday,
September 24, 2014, from 8 a.m. to 5:30 p.m. The meeting may close
early if all business is finished. All submitted written materials,
comments, and requests to make an oral presentation at the meeting
should reach Jack Kemerer, Alternate Designated Federal Officer for the
Commercial Fishing Safety Advisory Committee, no later than September
16, 2014. For contact information, please see the FOR FURTHER
INFORMATION CONTACT section below. Any written material submitted by
the public both before and after the meeting will be distributed to the
Commercial Fishing Safety Advisory Committee and become part of the
public record.

ADDRESSES: The Committee will meet at Rhode Island Department of
Environmental Management Headquarters located at 235 Promenade Street,
Providence, Rhode Island, Room 300.
    For information on facilities or services for individuals with
disabilities or to request special assistance at the meeting, contact
the person listed in the FOR FURTHER INFORMATION CONTACT section, as
soon as possible.
    To facilitate public participation, we are inviting public comment
on the issues to be considered by the Committee as listed in the
``Agenda'' section below. Written comments must be submitted no later
than September 16, 2014 if you want Committee members to be able to
review it before the meeting, and must be identified by docket number
USCG-2014-0801, and submitted by one of the following methods:
     Federal Electronic Rulemaking Portal: http://www.regulations.gov (preferred method to avoid delays in processing).
     Mail: Docket Management Facility (M-30), United States
Department of Transportation, West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC 20590-0001.
     Facsimile:<PHONE_NUMBER>.
     Hand Delivery: Same as mail address above, between 9 a.m.
and 5 p.m., Monday through Friday, except Federal Holidays. The
telephone number is<PHONE_NUMBER>. Instructions: All submissions
received must include the words ``Department of Homeland Security'' and
docket number for this action. Comments received will be posted without
alteration at www.regulations.gov, including any personal information
provided. You may review a Privacy Act notice regarding our public
dockets in the January 17, 2008 issue of the Federal Register (73 FR
3316). Docket: For access to the docket to read documents or comments
related to this notice, go to http://www.regulations.gov, enter the
docket number in the ``SEARCH'' box, press Enter and then click on the
item you wish to view.
    Public oral comment periods will be held during the meeting after
each presentation and at the end of each day. Speakers are requested to
limit their comments to 3 minutes. Please note that the public oral
comment periods may end before the prescribed ending time following the
last call for comments. Contact Jack Kemerer as indicated below to
register as a speaker.

FOR FURTHER INFORMATION CONTACT: Jack Kemerer, Alternate Designated
Federal Officer of Commercial Fishing Safety Advisory Committee,
Commandant (CG-CVC-3), United States Coast Guard Headquarters, 2703
Martin Luther King Junior Avenue SE., Mail Stop 7501, Washington, DC
20593-7501; telephone<PHONE_NUMBER>, facsimile<PHONE_NUMBER>, electronic
mail<EMAIL_ADDRESS>If you have any questions on viewing or
submitting material to the docket, call Cheryl Collins, Program
Manager, Docket Operations, telephone<PHONE_NUMBER> or 1-800-647-5527.

SUPPLEMENTARY INFORMATION: Notice of this meeting is given under the
Federal Advisory Committee Act, Title 5 United States Code Appendix.

    The Commercial Fishing Safety Advisory Committee is authorized by
Title 46 United States Code Section 4508 and the Committee's purpose is
to provide advice and recommendations to the United States Coast Guard
and the Department of Homeland Security on matters relating to the
safety of commercial fishing industry vessels.
    A copy of all meeting documentation is available at http://fishsafe.info/ Alternatively, you may contact Jack Kemerer as noted in
the FOR FURTHER INFORMATION CONTACT section above.

Agenda

    The Commercial Fishing Safety Advisory Committee will meet to
review, discuss and formulate recommendations on topics contained in
the agenda:

Day 1

    The meeting will include administrative matters, reports,
presentations, discussions, and Subcommittee sessions as follows:
    (1) Swearing-in of new members, election of Chair and Vice-Chair,
and completion of Department of Homeland Security Form 420 by Special
Government Employee members.
    (2) Status of Commercial Fishing Vessel Safety Rulemaking projects
resulting from requirements set forth in the Coast Guard Authorization
Act of 2010 and the Coast Guard and Maritime Transportation Act of
2012.
    (3) Commercial Fishing Vessel Safety District Coordinators' reports
on activities and initiatives.
    (4) Industry Representatives' updates on safety and survival
equipment, and classification of new fishing vessels.
    (5) Presentation and discussion on fatality rates by regions and
fisheries and update on safety and risk reduction related projects by
the National Institute for Occupational Safety and Health.
    (6) Presentation and discussion on safety standards by the National
Oceanic and Atmospheric Administration, National Marine Fisheries
Service.
    (7) Subcommittee/working group sessions on (a) standards for
alternative safety compliance program(s) development, and (b) training
program requirements for individuals in charge of a vessel and engineer
officer qualifications.
    (8) Public comment period.
    (9) Adjournment of meeting.
    There will be a comment period for Commercial Fishing Safety
Advisory Committee members and a comment period for the public after
each presentation and discussion. The Committee will review the
information presented on any issues, deliberate on any recommendations
presented in Subcommittee reports, and formulate recommendations for
the Department's consideration.

Day 2

    The meeting will primarily be dedicated to continuing Subcommittee/
working group sessions on training requirements and alternative safety
compliance programs, but will also include:
    (1) Reports and recommendations from the Subcommittees to the full
committee for consideration.
    (2) Other safety recommendations and safety program strategies from
the Committee.
    (3) Public comment period
    (4) Future plans and goals for the Committee.
    (5) Adjournment of meeting.

    Dated: August 28, 2014.
Jonathan C. Burton,
Captain, United States Coast Guard, Director of Inspections and
Compliance.
[FR Doc. 2014-20883 Filed 9-2-14; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 79, Number 103 (Thursday, May 29, 2014)]
[Notices]
[Pages 30921-30922]
[FR Doc No: 2014-12432]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[ File No. 500-1]

 In the Matter of OCTuS, Inc., Pacific Coast National Bancorp,
Travelstar, Inc., We Save Homes, Inc., and ZVUE Corp., Order of
Suspension of Trading

May 23, 2014.
    It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
OCTuS, Inc. because it has not filed any periodic reports since the
period ended March 31, 2011.
    It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Pacific Coast National Bancorp because it has not filed any periodic
reports since the period ended December 31, 2008.
    It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
Travelstar, Inc. because it has not filed any periodic reports since
the period ended March 31, 2008.
    It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
We Save Homes, Inc. because it has not filed any periodic reports since
the period ended September 30, 2010.
    It appears to the Securities and Exchange Commission that there is
a lack of current and accurate information concerning the securities of
ZVUE Corporation because it has not filed any periodic reports since
the period ended September 30, 2008.
    The Commission is of the opinion that the public interest and the
protection of investors require a suspension of trading in the
securities of the above-listed companies. Therefore, it is ordered,
pursuant to Section 12(k) of the

Securities Exchange Act of 1934, that trading in the securities of the
above-listed companies is suspended for the period from 9:30 a.m. EDT
on May 23, 2014, through 11:59 p.m. EDT on June 6, 2014.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2014-12432 Filed 5-23-14; 11:15 am]
BILLING CODE 8011-01-P


[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Pages 48797-48798]
[FR Doc No: 2021-18780]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2008-0355; FMCSA-2011-0089; FMCSA-2014-0381; FMCSA-
2014-0382; FMCSA-2017-0253; FMCSA-2018-0057; FMCSA-2019-0028; FMCSA-
2019-0029]

Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to renew exemptions for 13
individuals from the requirement in the Federal Motor Carrier Safety
Regulations (FMCSRs) that interstate commercial motor vehicle (CMV)
drivers have ``no established medical history or clinical diagnosis of
epilepsy or any other condition which is likely to cause loss of
consciousness or any loss of ability to control a CMV.'' The exemptions
enable these individuals who have had one or more seizures and are
taking anti-seizure medication to continue to operate CMVs in
interstate commerce.

DATES: The exemptions were applicable on July 12, 2021. The exemptions
expire on July 12, 2023.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
DOT, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through
Friday, except Federal holidays. If you have questions regarding
viewing or submitting material to the docket, contact Dockets
Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Viewing Comments

    To view comments go to www.regulations.gov. Insert the docket
number, FMCSA-2008-0355, FMCSA-2011-0089, FMCSA-2014-0381, FMCSA-2014-
0382, FMCSA-2017-0253, FMCSA-2018-0057, FMCSA-2019-0028, or FMCSA-2019-
0029 in the keyword box, and click ``Search.'' Next, sort the results
by ``Posted (Newer-Older),'' choose the first notice listed, and click
``Browse Comments.'' If you do not have access to the internet, you may
view the docket online by visiting Dockets Operations in Room W12-140
on the ground floor of the DOT West Building, 1200 New Jersey Avenue
SE, Washington, DC 20590-0001, between 9 a.m. and 5 p.m., ET, Monday
through Friday, except Federal holidays. To be sure someone is there to
help you, please call<PHONE_NUMBER> or<PHONE_NUMBER> before visiting
Dockets Operations.

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its regulatory process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.transportation.gov/privacy.

II. Background

    On July 15, 2021, FMCSA published a notice announcing its decision
to renew exemptions for 13 individuals from the epilepsy and seizure
disorders prohibition in 49 CFR 391.41(b)(8) to operate a CMV in
interstate commerce and requested comments from the public (86 FR
37397). The public comment period ended on August 16, 2021, and no
comments were received.
    FMCSA has evaluated the eligibility of these applicants and
determined that renewing these exemptions would achieve a level of
safety equivalent to, or greater than, the level that would be achieved
by complying with Sec.  391.41(b)(8).
    The physical qualification standard for drivers regarding epilepsy
found in Sec.  391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control a CMV.
    In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners in determining whether drivers
with certain medical conditions are qualified to operate a CMV in
interstate commerce.
---------------------------------------------------------------------------

    \1\ These criteria may be found in Appendix A to Part 391--
Medical Advisory Criteria, section H. Epilepsy: Sec.  391.41(b)(8),
paragraphs 3, 4, and 5, which is available on the internet at
https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

III. Discussion of Comments

    FMCSA received no comments in this preceding.

IV. Conclusion

    Based on its evaluation of the 13 renewal exemption applications,
FMCSA announces its decision to exempt the following drivers from the
epilepsy and seizure disorders prohibition in Sec.  391.41(b)(8).
    As of July 12, 2021, and in accordance with 49 U.S.C. 31136(e) and
31315(b), the following 13 individuals have satisfied the renewal
conditions for obtaining an exemption from the epilepsy and seizure
disorders prohibition in the FMCSRs for interstate CMV drivers (86 FR
37397):

Prince Austin, Jr. (OH)
Darcy Baker (OH)
Gary Bartels (SD)
Frank Cekovic (PA)
Monte DeRocini (PA)
Teddy Dixon (GA)
Jaime Dougherty (MN)
Martin Ford (WI)
David Johnston (HI)
Brent Mapes (IL)
Enrico Mucci (PA)
Charles Skelton (AL)
Kevin Wiggins (KY)

    The drivers were included in docket number FMCSA-2008-0355,
    FMCSA-2011-0089, FMCSA-2014-0381, FMCSA-2014-0382, FMCSA-2017-0253,
FMCSA-2018-0057, FMCSA-2019-0028, or FMCSA-2019-0029. Their exemptions
were applicable as of July 12, 2021 and will expire on July 12, 2023.
    In accordance with 49 U.S.C. 31315(b), each exemption will be valid
for 2 years from the effective date unless revoked earlier by FMCSA.
The exemption will be revoked if the following occurs: (1) The person
fails to comply with the terms and conditions of the exemption; (2) the
exemption has resulted in a lower level of safety than was maintained
prior to being granted; or (3) continuation of the exemption would not
be consistent with the goals and objectives of 49 U.S.C. 31136(e) and
31315(b).

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2021-18780 Filed 8-30-21; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Rules and Regulations]
[Pages 65007-65009]
[FR Doc No: 2019-25595]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R01-OAR-2019-0348; FRL-10002-42-Region 1]

Air Plan Approval; Connecticut; Regional Haze Five Year Progress
Report

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is approving the
Connecticut Regional Haze 5-Year Progress Report submitted as a State
Implementation Plan (SIP) revision on June 30, 2015. This revision
addresses the requirements of the Clean Air Act and its implementing
regulations that States submit periodic reports describing progress
toward reasonable progress goals established for regional haze and a
determination of adequacy of the State's existing regional haze SIP.

Connecticut's progress report notes that Connecticut has made
substantial progress toward the emissions reduction expected for the
first regional planning period and that visibility in the Federal Class
I areas affected by emission from Connecticut is improving and has
already met the applicable reasonable progress goals for 2018. The EPA
is approving Connecticut's determination that the State's regional haze
SIP is adequate to meet these reasonable progress goals for the first
implementation period, which extends through 2018, and requires no
substantive revision at this time.

DATES: This rule is effective on December 26, 2019.

ADDRESSES: EPA has established a docket for this action under Docket
Identification No. EPA-R01-OAR-2019-0348. All documents in the docket
are listed on the https://www.regulations.gov website. Although listed
in the index, some information is not publicly available, i.e., CBI or
other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
internet and will be publicly available only in hard copy form.
Publicly available docket materials are available at https://www.regulations.gov or at the U.S. Environmental Protection Agency, EPA
Region 1 Regional Office, Air and Radiation Division, 5 Post Office
Square--Suite 100, Boston, MA. EPA requests that if at all possible,
you contact the contact listed in the FOR FURTHER INFORMATION CONTACT
section to schedule your inspection. The Regional Office's official
hours of business are Monday through Friday, 8:30 a.m. to 4:30 p.m.,
excluding legal holidays.

FOR FURTHER INFORMATION CONTACT: Anne K. McWilliams, Air Quality
Branch, U.S. Environmental Protection Agency, EPA Region 1, 5 Post
Office Square--Suite 100, (Mail code 05-2), Boston, MA 02109-3912, tel.
(617) 918-1697, email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Throughout this document whenever ``we,''
``us,'' or ``our'' is used, we mean EPA.

Table of Contents

I. Background and Purpose
II. Final Action
II. Statutory and Executive Order Reviews

I. Background and Purpose

    On September 25, 2019 (84 FR 50363), EPA published a notice of
proposed rulemaking (NPRM) for the State of Connecticut proposing
approval of the Regional Haze 5-Year Progress Report and a
determination of adequacy of the regional haze plan for the first
planning period. The formal SIP revision was submitted by Connecticut
on June 30, 2015.
    The rationale for EPA's proposed action is explained in the NPRM
and will not be restated here. No public comments were received on the
NPRM.

II. Final Action

    EPA is approving Connecticut's June 30, 2015 Regional Haze 5-Year
Progress Report SIP submittal and determination of adequacy of the
regional haze plan for the first planning period as meeting the
requirements of 40 CFR 51.308(g) and (h).

III. Statutory and Executive Order Reviews

    Under the Clean Air Act, the Administrator is required to approve a
SIP submission that complies with the provisions of the Act and
applicable Federal regulations. 42 U.S.C. 7410(k); 40 CFR 52.02(a).
Thus, in reviewing SIP submissions, EPA's role is to approve state
choices, provided that they meet the criteria of the Clean Air Act.
Accordingly, this action merely approves state law as meeting Federal
requirements and does not impose additional requirements beyond those
imposed by state law. For that reason, this action:
     Is not a significant regulatory action subject to review
by the Office of Management and Budget under Executive Orders 12866 (58
FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011);
     Is not an Executive Order 13771 regulatory action because
this action is not significant under Executive Order 12866;
     Does not impose an information collection burden under the
provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.);
     Is certified as not having a significant economic impact
on a substantial number of small entities under the Regulatory
Flexibility Act (5 U.S.C. 601 et seq.);
     Does not contain any unfunded mandate or significantly or
uniquely affect small governments, as described in the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4);
     Does not have federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999);
     Is not an economically significant regulatory action based
on health or safety risks subject to Executive Order 13045 (62 FR
19885, April 23, 1997);
     Is not a significant regulatory action subject to
Executive Order 13211 (66 FR 28355, May 22, 2001);
     Is not subject to requirements of Section 12(d) of the
National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272
note) because application of those requirements would be inconsistent
with the Clean Air Act; and
     Does not provide EPA with the discretionary authority to
address, as appropriate, disproportionate human health or environmental
effects, using practicable and legally permissible methods, under
Executive Order 12898 (59 FR 7629, February 16, 1994).
    In addition, the SIP is not approved to apply on any Indian
reservation land or in any other area where EPA or an Indian tribe has
demonstrated that a tribe has jurisdiction. In those areas of Indian
country, the rule does not have tribal implications and will not impose
substantial direct costs on tribal governments or preempt tribal law as
specified by Executive Order 13175 (65 FR 67249, November 9, 2000).
    The Congressional Review Act, 5 U.S.C. 801 et seq., as added by the
Small Business Regulatory Enforcement Fairness Act of 1996, generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report, which includes a copy of the rule,
to each House of the Congress and to the Comptroller General of the
United States. EPA will submit a report containing this action and
other required information to the U.S. Senate, the U.S. House of
Representatives, and the Comptroller General of the United States prior
to publication of the rule in the Federal Register. A major rule cannot
take effect until 60 days after it is published in the Federal
Register. This action is not a ``major rule'' as defined by 5 U.S.C.
804(2).
    Under section 307(b)(1) of the Clean Air Act, petitions for
judicial review of this action must be filed in the United States Court
of Appeals for the appropriate circuit by January 27, 2020. Filing a
petition for reconsideration by the Administrator of this final rule
does not affect the finality of this action for the purposes of
judicial review nor does it extend the time within which a petition for
judicial review may be filed, and shall not postpone the effectiveness
of such rule or action. This action may not be challenged later in
proceedings to enforce its requirements. (See section 307(b)(2).)

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Carbon monoxide,
Incorporation by reference,

Intergovernmental relations, Lead, Nitrogen dioxide, Ozone, Particulate
matter, Regional haze, Reporting and recordkeeping requirements, Sulfur
oxides, Volatile organic compounds.

    Dated: November 19, 2019.
Dennis Deziel,
Regional Administrator, EPA Region 1.

    Part 52 of chapter I, title 40 of the Code of Federal Regulations
is amended as follows:

PART 52--APPROVAL AND PROMULGATION OF IMPLEMENTATION PLANS

0
1. The authority citation for part 52 continues to read as follows:

    Authority: 42 U.S.C. 7401 et seq.

Subpart H--Connecticut

0
2. Section 52.370 is amended by adding paragraph (c)(121) to read as
follows:

 Sec.  52.370  Identification of plan.

* * * * *
    (c) * * *
    (121) Revisions to the State Implementation Plan submitted by the
Connecticut Department of Energy and Environmental Protection on June
30, 2015.
    (i) [Reserved]
    (ii) Additional materials. (A) The Connecticut Department of Energy
and Environmental Protection document ``Regional Haze 5-Year Progress
Report,'' Final July 8, 2015.
    (B) [Reserved]

[FR Doc. 2019-25595 Filed 11-25-19; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 79, Number 244 (Friday, December 19, 2014)]
[Proposed Rules]
[Pages 75772-75773]
[FR Doc No: 2014-29774]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Parts 403 and 441

[EPA-HQ-OW-2014-0693; FRL-9920-66-OW]
RIN 2040-AF26

Effluent Limitations Guidelines and Standards for the Dental
Category; Extension of Comment Period

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: EPA received requests for an extension of the period for
providing comments on the proposed rule entitled, ``Effluent
Limitations Guidelines and Standards for the Dental Category,''
published in the Federal Register on October 22, 2014. EPA is extending
the comment period from December 22, 2014 to February 20, 2015.

DATES: Comments. The public comment period for the proposed rule
published October 22, 2014 (79 FR 63258) is being extended to February
20, 2015, in order to provide the public additional time to submit
comments and supporting information.

ADDRESSES: Comments. Written comments on the proposed rule may be
submitted to the EPA electronically, by mail, by facsimile or through
hand delivery/courier. Please refer to the proposal (79 FR 63258) for
the addresses and detailed instructions.

    Docket. Publically available documents relevant to this action are
available for public inspection either electronically at http://www.regulations.gov or in hard copy at the Water Docket in the EPA
Docket Center, EPA/DC, EPA West, Room 3334, 1301 Constitution Ave. NW.,
Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The telephone
number for the Public Reading Room is<PHONE_NUMBER>, and the telephone
number for the Water Docket is<PHONE_NUMBER>. The EPA has established
the official public docket no. EPA-HQ-OW-2014-0693.

FOR FURTHER INFORMATION CONTACT: Damon Highsmith, Engineering and
Analysis Division (4303T), Office of Water, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001;
telephone:<PHONE_NUMBER>; email<EMAIL_ADDRESS>
List of Subjects in 40 CFR Parts 403 and 441

    Environmental protection, Dental, Dental office, Dentist, Mercury,
Pretreatment, Waste treatment and disposal, Water pollution control.

    Dated: December 12, 2014.
Kenneth J. Kopocis,
Deputy Assistant Administrator, Office of Water.
[FR Doc. 2014-29774 Filed 12-18-14; 8:45 am]
BILLING CODE 6560-50-P